Cancer Stem Cells and Drug Resistance

Cancer stem cells are cancer cells that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic (tumor-forming), perhaps in contrast to other non-tumorigenic cancer cells. The "mutation in stem cell niche populations during development" hypothesis claims that these developing stem populations are mutated and then reproduce so that the mutation is shared by many descendants. These daughter cells are much closer to becoming tumors and their numbers increase the chance of a cancerous mutation. De-differentiation of mutated cells may create stem cell-like characteristics, suggesting that any cell might become a cancer stem cell.

    Related Conference of Cancer Stem Cells and Drug Resistance

    March 30-31, 2018

    Orlando, USA
    June 25-26, 2018

    2nd International Conference on Microbial Pathogenesis and Infectious Diseases

    Vancouver, Canada
    (10 Plenary Forums, 2 Days, 1 Event)
    June 20-21, 2018

    15th European Pathology Congress

    | Paris, France
    June 25-26, 2018

    15th CME Congress on Pathology and Cancer Research

    Vancouver, Canada
    August 29-30, 2018

    4th International Conference on Cytopathology & Histopathology

    Boston | Massachusetts | USA
    Sep 17-18, 2018

    16th Asia Pacific Pathology Congress

    Tokyo, Japan

    Cancer Stem Cells and Drug Resistance Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in